Reuters: AstraZeneca sees study fuelling Crestor sales

[chris]

AstraZeneca sees study fuelling Crestor sales
      

LONDON (Reuters) - A study showing Crestor reduces the risk of death and heart problems in some patients with low or normal cholesterol will be key to the future sales of the medicine, its maker AstraZeneca Plc  said on Tuesday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login